Lipids in Health and Disease

Table 4 Measurement of oxidation-modified LDL antibodies, oxidative status, and parameters of blood in patients with myocardial infarction on the 1st and 12th days of the disease

From: Multivessel coronary artery disease, free fatty acids, oxidized LDL and its antibody in myocardial infarction

Variables	Control, n = 33	Group 1, ≥ 75% stenosis of a coronary artery, n = 135		Group 2, ≥ 75% stenosis 2 coronary, n = 115		Group 3, ≥ 75% stenosis of 3 or more coronary arteries, n = 150
Variables	Control, n = 33	1-th day	12-th day	1-th day	12-th day	1-th day	12-th day
Oxidized LDL, ng/mL	359.69 (324.56;389.23)	384.14 (349.52;412.1)	481.55 (411.25;533.21)^b	409.13 (379.26;430.14)^ac	605.23 (556.98;352.15)^bc	717.16 (689.65;745.68)^acd	1023.74 (956.21;1068.21)^bcd
Oxidized LDL antibody, mU/mL	206.82 (189.63;225.32)	284.36 (251.23;312.23)^a	395.72 (374.25;423.21)^b	334.08 (316.59;354.12)^ac	382.05 (369.24;399.96)^bc	484.47 (459,82;509.51)^acd	545.59 (521.32;574.25)^bcd
Serum protein thiol, mcmol/L	515.1 (501.52;545.25)	646.42 (610.75;689.65)^a	738.24 (698.23;769.6)^b	735.84 (695.24;774.23)^a	768.44 (726.24;789.65)	722.26 (692.12;761.15)^a	753.34 (721.65;786.12)
Peroxide, mcmol/L	194.8 (189.32;208.45)	370.88 (345.26;396.21)^a	451.05(423,89;478.21)	362.34 (326.25;386.25)^a	408.85 (374.28;432.51)	391.00 (379.25;413.58)^a	454.99 (423.11;489.25)

Note: ^a - reliable differences in the parameters with the control group, (p ≤ 0.05).
^b - reliable difference parameters on day 1 and 12, (p ≤ 0.05).
^c - reliable difference between 1 and 2, groups 1 and 3, (p ≤ 0.05).
^d - reliable differences in the parameters between groups 2 and 3, (p ≤ 0.05)

Back to article page

ISSN: 1476-511X

Contact us

General enquiries: journalsubmissions@springernature.com